Glaxo Takes Aim at Covid-19 in $250 Million Pact With Vir

Bookmark
(Bloomberg) -- U.K. pharmaceutical giant GlaxoSmithKline Plc is joining dozens of companies in the hunt for coronavirus therapies, signing a partnership with Vir Biotechnology Inc. and agreeing to ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.